This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Fabtech approves Q1 and Q2 FY26 results; Q1 revenue up 136%, loss of Rs 612.59 lakh
FABTECH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.4 pts more than Nifty Microcap 250 and 9.8 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved unaudited June 2025 quarter and September 2025 quarter and half-year results. For the June quarter, consolidated revenue rose to Rs 6,800.68 lakh from Rs 2,875.01 lakh, but the group posted a net loss of Rs 612.59 lakh against profit of Rs 578.60 lakh last year. Standalone loss was Rs 916.04 lakh. An exceptional gain of Rs 177.49 lakh came from selling 51% of a subsidiary. The review report was unmodified.
Strong revenue growth but a swing to loss; near-term earnings sentiment may stay weak, though the one-off stake sale added support.
| Q2 FY26 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹121.5 Cr | — | — |
| Operating profit | ₹28.08 Cr | — | — |
| Profit after tax | ₹28.11 Cr | — | — |
| EBITDA margin | 25.1% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.